vs
AMTECH SYSTEMS INC（ASYS）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是AMTECH SYSTEMS INC的1.0倍（$19.6M vs $19.0M），AMTECH SYSTEMS INC净利率更高（0.6% vs -177.4%，领先178.0%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -22.2%），AMTECH SYSTEMS INC自由现金流更多（$3.8M vs $-23.1M），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -13.6%）
Amtech Systems Inc是一家全球领先的热处理及自动化设备制造商，核心产品面向半导体、光伏太阳能、LED生产领域，覆盖焊接、扩散、沉积等工艺设备，主要市场包括北美、东亚及西欧，服务电子元器件、清洁能源制造领域的头部客户。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ASYS vs LAB — 直观对比
营收规模更大
LAB
是对方的1.0倍
$19.0M
营收增速更快
LAB
高出10.7%
-22.2%
净利率更高
ASYS
高出178.0%
-177.4%
自由现金流更多
ASYS
多$26.9M
$-23.1M
两年增速更快
LAB
近两年复合增速
-13.6%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.0M | $19.6M |
| 净利润 | $108.0K | $-34.7M |
| 毛利率 | 44.8% | 48.5% |
| 营业利润率 | 4.1% | -168.5% |
| 净利率 | 0.6% | -177.4% |
| 营收同比 | -22.2% | -11.5% |
| 净利润同比 | -65.4% | -28.8% |
| 每股收益（稀释后） | $0.01 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASYSLAB
| Q4 25 | $19.0M | — | ||
| Q3 25 | $19.8M | $19.6M | ||
| Q2 25 | $19.6M | $21.8M | ||
| Q1 25 | $15.6M | $40.8M | ||
| Q4 24 | $24.4M | — | ||
| Q3 24 | $24.1M | $22.1M | ||
| Q2 24 | $26.7M | $22.5M | ||
| Q1 24 | $25.4M | $45.5M |
净利润ASYSLAB
| Q4 25 | $108.0K | — | ||
| Q3 25 | $1.1M | $-34.7M | ||
| Q2 25 | $106.0K | $-33.5M | ||
| Q1 25 | $-31.8M | $-26.0M | ||
| Q4 24 | $312.0K | — | ||
| Q3 24 | $-536.0K | $-26.9M | ||
| Q2 24 | $438.0K | $-45.7M | ||
| Q1 24 | $970.0K | $-32.2M |
毛利率ASYSLAB
| Q4 25 | 44.8% | — | ||
| Q3 25 | 44.4% | 48.5% | ||
| Q2 25 | 46.7% | 48.8% | ||
| Q1 25 | -2.1% | 48.4% | ||
| Q4 24 | 38.4% | — | ||
| Q3 24 | 40.7% | 54.9% | ||
| Q2 24 | 36.5% | 46.1% | ||
| Q1 24 | 33.2% | 53.1% |
营业利润率ASYSLAB
| Q4 25 | 4.1% | — | ||
| Q3 25 | 9.3% | -168.5% | ||
| Q2 25 | 4.7% | -118.1% | ||
| Q1 25 | -202.7% | -80.8% | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 0.1% | -120.9% | ||
| Q2 24 | 3.1% | -134.5% | ||
| Q1 24 | 5.4% | -132.2% |
净利率ASYSLAB
| Q4 25 | 0.6% | — | ||
| Q3 25 | 5.4% | -177.4% | ||
| Q2 25 | 0.5% | -153.7% | ||
| Q1 25 | -204.2% | -63.8% | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | -2.2% | -122.0% | ||
| Q2 24 | 1.6% | -203.3% | ||
| Q1 24 | 3.8% | -70.6% |
每股收益（稀释后）ASYSLAB
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.08 | $-0.09 | ||
| Q2 25 | $0.01 | $-0.09 | ||
| Q1 25 | $-2.23 | $-0.07 | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $-0.04 | $-0.07 | ||
| Q2 24 | $0.03 | $-0.12 | ||
| Q1 24 | $0.07 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.1M | $129.4M |
| 总债务越低越好 | $162.0K | — |
| 股东权益账面价值 | $54.1M | $399.7M |
| 总资产 | $94.1M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ASYSLAB
| Q4 25 | $22.1M | — | ||
| Q3 25 | $17.9M | $129.4M | ||
| Q2 25 | $15.6M | $158.6M | ||
| Q1 25 | $13.4M | $150.9M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $11.1M | $210.6M | ||
| Q2 24 | $13.2M | $269.8M | ||
| Q1 24 | $13.0M | $287.1M |
总债务ASYSLAB
| Q4 25 | $162.0K | — | ||
| Q3 25 | $168.0K | — | ||
| Q2 25 | $127.0K | — | ||
| Q1 25 | $135.0K | — | ||
| Q4 24 | $161.0K | — | ||
| Q3 24 | $189.0K | $55.2M | ||
| Q2 24 | $177.0K | $55.1M | ||
| Q1 24 | $65.0K | $55.0M |
股东权益ASYSLAB
| Q4 25 | $54.1M | — | ||
| Q3 25 | $53.4M | $399.7M | ||
| Q2 25 | $51.7M | $424.5M | ||
| Q1 25 | $51.0M | $454.6M | ||
| Q4 24 | $82.4M | — | ||
| Q3 24 | $82.4M | $489.3M | ||
| Q2 24 | $81.7M | $510.3M | ||
| Q1 24 | $80.9M | $577.3M |
总资产ASYSLAB
| Q4 25 | $94.1M | — | ||
| Q3 25 | $92.9M | $539.6M | ||
| Q2 25 | $89.5M | $557.0M | ||
| Q1 25 | $83.4M | $579.6M | ||
| Q4 24 | $117.8M | — | ||
| Q3 24 | $119.3M | $681.5M | ||
| Q2 24 | $127.1M | $708.7M | ||
| Q1 24 | $116.5M | $777.7M |
负债/权益比ASYSLAB
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | 0.11× | ||
| Q2 24 | 0.00× | 0.11× | ||
| Q1 24 | 0.00× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.1M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $3.8M | $-23.1M |
| 自由现金流率自由现金流/营收 | 20.2% | -118.1% |
| 资本支出强度资本支出/营收 | 1.5% | 4.5% |
| 现金转化率经营现金流/净利润 | 37.99× | — |
| 过去12个月自由现金流最近4个季度 | $8.0M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流ASYSLAB
| Q4 25 | $4.1M | — | ||
| Q3 25 | $2.3M | $-22.2M | ||
| Q2 25 | $2.5M | $-20.7M | ||
| Q1 25 | $210.0K | $-30.3M | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $879.0K | $-27.9M | ||
| Q2 24 | $3.7M | $-39.0M | ||
| Q1 24 | $336.0K | $-62.5M |
自由现金流ASYSLAB
| Q4 25 | $3.8M | — | ||
| Q3 25 | $2.0M | $-23.1M | ||
| Q2 25 | $2.0M | $-22.6M | ||
| Q1 25 | $201.0K | $-35.3M | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $447.0K | $-30.1M | ||
| Q2 24 | $322.0K | $-41.0M | ||
| Q1 24 | $-884.0K | $-63.3M |
自由现金流率ASYSLAB
| Q4 25 | 20.2% | — | ||
| Q3 25 | 10.2% | -118.1% | ||
| Q2 25 | 10.1% | -103.6% | ||
| Q1 25 | 1.3% | -86.6% | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 1.9% | -136.4% | ||
| Q2 24 | 1.2% | -182.2% | ||
| Q1 24 | -3.5% | -138.9% |
资本支出强度ASYSLAB
| Q4 25 | 1.5% | — | ||
| Q3 25 | 1.2% | 4.5% | ||
| Q2 25 | 2.8% | 8.7% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 1.8% | 10.2% | ||
| Q2 24 | 12.5% | 8.6% | ||
| Q1 24 | 4.8% | 1.7% |
现金转化率ASYSLAB
| Q4 25 | 37.99× | — | ||
| Q3 25 | 2.12× | — | ||
| Q2 25 | 23.89× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 9.19× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 8.35× | — | ||
| Q1 24 | 0.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASYS
| Thermal Processing Solutions | $14.0M | 74% |
| Semiconductor Fabrication Solutions | $5.0M | 26% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
